FMP
Jan 20, 2026
3M Company (NYSE:MMM) is a diversified technology company known for its wide range of products, including adhesives, abrasives, and personal protective equipment. The company operates in various sectors, such as healthcare, consumer goods, and industrial products. 3M faces competition from companies like Honeywell and DuPont in the industrial and consumer markets.
On January 20, 2026, 3M reported earnings per share (EPS) of $1.83, surpassing the estimated $1.81. The company generated a revenue of $6.1 billion, suprassing estimated $6.008 billion. Despite this earnings beat, 3M's stock is experiencing a decline, as highlighted by Barron's. The stock is under pressure due to disappointing profit forecasts for 2026, which have fallen short of estimates.
3M's fourth-quarter performance showed adjusted earnings of $1.83 per share on revenue of $6.1 billion, both exceeding analyst expectations. However, the stock is down 3.8% at $161.43, partly due to a broad-market selloff. The stock has been trading within a narrow range since reaching a three-year peak of $174.69 on December 3, but it has increased by 14.1% year over year.
The company's financial results for the fourth quarter and full year of 2025 reveal a mixed performance. While GAAP sales increased by 2.1% year-over-year to $6.1 billion, the operating margin decreased by 510 basis points to 13.0%. On an adjusted basis, sales were $6.0 billion with an organic growth of 2.2%, and the adjusted operating margin improved by 140 basis points to 21.1%.
For the full year, 3M's GAAP sales reached $24.9 billion, a 1.5% increase from the previous year. The adjusted EPS for the year was $8.06, reflecting a 10% increase. Despite the challenges, 3M's Chairman and CEO, William Brown, expressed confidence in the company's ability to continue outperforming the macro environment in 2026, focusing on innovation and commercial execution.
D.R. Horton (NYSE: DHI) reported fiscal first-quarter net sales orders that came in below Wall Street expectations, as t...
Amgen Inc. (NASDAQ:AMGN) is a leading pharmaceutical company known for its innovative therapies and treatments. On Janua...